• Our Company>open
    • Who is SCC?>open
      • Our Philosophy
      • Our Expertise
      • Our Services
    • SCC Headquarters
    • Office Berlin>open
      • Contact Our Experts
    • SCC Japan>open
      • Food Contact Materials Japan
      • Chemicals Japan
      • Contact Our Experts
      • Genetically Modified Crop - Japan
    • SCC UK>open
      • Contact Our Experts
    • How to Find Us>open
      • Headquarters Bad Kreuznach>open
        • City of Bad Kreuznach
      • Office Berlin
      • SCC Japan
  • EU Services>open
    • Agrochemicals & Biorationals>open
      • Agrochemicals
      • Biorationals
      • Biostimulants and fertilisers
      • Organic farming
      • Approval status of active substances
      • Efficacy
      • CADDY
      • Regulatory Service
      • Study Monitoring
      • Task Force/Consortium Management
      • Links
      • Contact Our Experts
    • Biocides>open
      • Biocidal Products
      • Active Substances
      • Approval status of active substances
      • Exposure and Risk Assessments
      • Study Monitoring
      • Biocidal Product Consortia
      • Call for Interest – Biocidal Product Consortia
      • IUCLID/R4BP
      • Links
      • Contact Our Experts
    • Chemicals>open
      • REACH Services
      • Only Representative
      • Consortia and SIEFs
      • Study Planning and Monitoring
      • CLP Services
      • Poison Centres Notification
      • SCIP notification
      • Safety Data Sheets
      • IUCLID
      • Links
      • Contact Our Experts
    • Regulatory Science>open
      • Efficacy
      • Study Monitoring
      • Modelling and Risk Assessment
      • Maximum Residue Levels
      • ERA
      • Task force/Consortium Management
      • Electronic Submission of Dossiers
      • Links
      • Contact Our Experts
    • Consumer Products>open
      • Study Monitoring
      • Links
      • Contact Our Experts
    • Cosmetics>open
      • Study Monitoring
      • Contact Our Experts
    • Feed & Food Additives>open
      • Feed Additives
      • Food Additives
      • Links
      • Contact Our Experts
    • Food Contact Materials>open
      • Contact Our Experts
    • Medical Devices>open
      • Requirements MDR (EU) 2017/745
      • Risk Assessment
      • Biological Evaluation
      • Clinical Evaluation
      • Qualification and Validation
      • International Approval
      • Links
      • Contact Our Experts
    • GLP & Regulatory Archiving>open
      • GLP
      • Regulatory Archive
      • Contact Our Experts
    • Pharma Pre-Clinical>open
      • Contact Our Experts
  • International Services>open
    • Agrochemicals & Biorationals>open
      • China
      • Eurasia Region
      • India
      • Latin America
      • United Kingdom
      • USA
      • Contact Our Experts
    • Biocides>open
      • China
      • Eurasia Region
      • South Korea
      • Turkey
      • United Kingdom
      • Contact Our Experts
    • Chemicals>open
      • Australia
      • China
      • Eurasian Economic Union
      • Japan
      • South Korea
      • Turkey
      • United Kingdom
      • USA
      • Contact Our Experts
    • Medical Devices>open
      • Contact Our Experts
  • News & Guidance>open
    • Current News
    • News Archive>open
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
      • 2011
      • 2010
      • 2009
      • 2008
      • 2007
      • 2006
      • 2005
    • Meet us
    • Regulatory Guidance>open
      • Regulatory Insights - Agrochemicals and Biorationals
      • Regulatory Guidance - Efficacy
      • Regulatory Insights - Chemicals
      • Approval status of agrochemical & biopesticidal active substances
      • Approval status of biocidal active substances
    • Newsletter>open
      • 2021
      • 2020>open
        • 2020-12 SCC Newsletter Foreword
        • 2020-12 SCC Newsletter - Efficacy and Product Performance – Subject of Change
        • 2020-12 SCC Newsletter - Efficacy testing - new EPPO standard
        • 2020-12 SCC Newsletter - Adjuvant registration
        • 2020-12 SCC Newsletter - Metabolites of microbial biocontrol agents
        • 2020-12 SCC Newsletter - K-BPR update
        • 2020-12 SCC Newsletter - Manual completeness check of CSRs
        • 2020-12 SCC Newsletter - EU's new chemicals strategy
        • 2020-12 SCC Newsletter - REACH registration update deadlines
        • 2020-12 SCC Newsletter - FOCUS degradation kinetics guidance
        • 2020-chemicals
        • 2020-biocides
        • 2020-meddev
        • 2020-08 NewsFlash SCC UK
        • 2020-08 NewsFlash UK REACH
        • 2020-08 NewsFlash SCC Online Academy
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
      • 2011
      • 2010
      • 2009
      • 2008
      • 2007
      • 2006
      • 2005
    • Subscribe to our newsletter
  • Careers>open
    • Why SCC?>open
      • Responsibility
      • Gain an impression of SCC
    • Professionals>open
      • Who we are looking for
    • Graduates>open
      • Who we are looking for
    • Open Positions
  • Contact>open
    • Contact us
Home   |   Services Overview: flagge japan flagge suedkorea flagge china flagge frankreich flagge italien flagge griechenland flagge spanien flagge turkish flagge deutschland
  • Current News
  • News Archive
  • Meet us
  • Regulatory Guidance
  • Newsletter
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
    • 2011
    • 2010
    • 2009
    • 2008
    • 2007
    • 2006
    • 2005
  • Subscribe to our newsletter

NL NewsFlash Letterhead 2020 05 

 

SCC Newsletter 2020 - NewsFlash

REGULATORY NEWSFLASH

Date: 5 May 2020

» MEDICAL DEVICES

One year delay in the implementation dates of the Medical Device Regulation (EU) 2017/745 due to COVID-19

An amendment relating to the dates of application of the new medical device regulation MDR (EU) 2017/745, decided by the European parliament on 17 April 2020, has been published and is in force. In the amendment, all dates referring to the original implementation date of 26 May 2020 have been replaced by 26 May 2021, with exception of the preparation of the guidelines on phthalates.

In addition to keeping the requirements for existing devices, this allows placing new or modified medical devices on the market under the Directives 93/42/EEC and 90/385/EEC up to this new implementation date next year. The deadlines for placing the UDI on the device and packaging, which were scheduled further in the future, remain unchanged.

If you have questions with respect to the impact on your company, please contact This email address is being protected from spambots. You need JavaScript enabled to view it..

Do you have any comments, questions or suggestions?
Drop us an email at This email address is being protected from spambots. You need JavaScript enabled to view it.



Subscribe to
our Newsletter

  • Legal notice
  • Privacy Policy
  • Impressum
  • Datenschutz
  • Sitemap